rs35311343

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003265.3(TLR3):​c.889C>G​(p.Leu297Val) variant causes a missense change. The variant allele was found at a frequency of 0.00203 in 1,614,170 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 4 hom. )

Consequence

TLR3
NM_003265.3 missense

Scores

2
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2O:2

Conservation

PhyloP100: 3.80

Publications

17 publications found
Variant links:
Genes affected
TLR3 (HGNC:11849): (toll like receptor 3) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor is most abundantly expressed in placenta and pancreas, and is restricted to the dendritic subpopulation of the leukocytes. It recognizes dsRNA associated with viral infection, and induces the activation of NF-kappaB and the production of type I interferons. It thus plays a role in host defense against multiple viruses. [provided by RefSeq, Jul 2021]
TLR3 Gene-Disease associations (from GenCC):
  • immunodeficiency 83, susceptibility to viral infections
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.035041124).
BP6
Variant 4-186082575-C-G is Benign according to our data. Variant chr4-186082575-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 495314.
BS2
High Homozygotes in GnomAdExome4 at 4 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR3NM_003265.3 linkc.889C>G p.Leu297Val missense_variant Exon 4 of 5 ENST00000296795.8 NP_003256.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR3ENST00000296795.8 linkc.889C>G p.Leu297Val missense_variant Exon 4 of 5 1 NM_003265.3 ENSP00000296795.3

Frequencies

GnomAD3 genomes
AF:
0.00167
AC:
254
AN:
152194
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00223
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00266
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00148
AC:
373
AN:
251348
AF XY:
0.00148
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.00124
Gnomad ASJ exome
AF:
0.00218
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000878
Gnomad NFE exome
AF:
0.00214
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00207
AC:
3020
AN:
1461858
Hom.:
4
Cov.:
37
AF XY:
0.00199
AC XY:
1448
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33480
American (AMR)
AF:
0.00134
AC:
60
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
60
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000951
AC:
82
AN:
86256
European-Finnish (FIN)
AF:
0.00120
AC:
64
AN:
53416
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.00236
AC:
2623
AN:
1111990
Other (OTH)
AF:
0.00184
AC:
111
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
173
346
520
693
866
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00167
AC:
254
AN:
152312
Hom.:
1
Cov.:
32
AF XY:
0.00132
AC XY:
98
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41576
American (AMR)
AF:
0.00222
AC:
34
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4824
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00266
AC:
181
AN:
68028
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00196
Hom.:
0
Bravo
AF:
0.00169
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00151
AC:
183
EpiCase
AF:
0.00218
EpiControl
AF:
0.00207

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2Other:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Susceptibility to HIV infection;C2751803:Immunodeficiency 83, susceptibility to viral infections Uncertain:1
Apr 16, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Herpes simplex encephalitis, susceptibility to, 1 Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Multisystem inflammatory syndrome in children Other:1
Nov 14, 2021
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:research

- -

Immunodeficiency 83, susceptibility to viral infections Other:1
Jul 12, 2021
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T;.
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.81
T;T
M_CAP
Uncertain
0.092
D
MetaRNN
Benign
0.035
T;T
MetaSVM
Uncertain
0.073
D
MutationAssessor
Pathogenic
2.9
M;.
PhyloP100
3.8
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-1.5
N;N
REVEL
Uncertain
0.47
Sift
Uncertain
0.0030
D;T
Sift4G
Uncertain
0.012
D;D
Polyphen
0.98
D;.
Vest4
0.65
MVP
0.93
MPC
0.57
ClinPred
0.059
T
GERP RS
5.4
Varity_R
0.64
gMVP
0.54
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35311343; hg19: chr4-187003729; COSMIC: COSV105111034; API